April 9, 2024Neurology2 citations

The Safety Profile of Fenebrutinib in Patients with Multiple Sclerosis Is Consistent with Those in Previously Studied Autoimmune Indications (P9-6.012)

Key points are not available for this paper at this time.

To compare the safety and tolerability of fenebrutinib in people with multiple sclerosis (MS) and those with autoimmune indications (AIs).

问 AI

Bookmark

View Full Paper

Cite This Study

Oh et al. (Tue,) studied this question.

问 AI

Bookmark

View Full Paper